KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 125 filers reported holding KEROS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,517,277 | -49.4% | 62,650 | -46.2% | 0.01% | -54.5% |
| Q1 2023 | $4,975,404 | +1518.9% | 116,520 | +1720.6% | 0.01% | +1000.0% |
| Q4 2022 | $307,328 | -79.0% | 6,400 | -87.9% | 0.00% | -66.7% |
| Q2 2022 | $1,464,000 | +260.6% | 52,934 | +608.8% | 0.00% | +200.0% |
| Q1 2022 | $406,000 | +21.2% | 7,468 | +30.4% | 0.00% | 0.0% |
| Q4 2021 | $335,000 | -82.9% | 5,727 | -88.5% | 0.00% | -87.5% |
| Q3 2021 | $1,964,000 | +283.6% | 49,636 | +311.7% | 0.01% | +300.0% |
| Q2 2021 | $512,000 | +41.4% | 12,055 | +105.1% | 0.00% | 0.0% |
| Q1 2021 | $362,000 | -70.7% | 5,877 | -66.4% | 0.00% | -71.4% |
| Q4 2020 | $1,234,000 | – | 17,492 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |